Skip to content

Walking for Wellbeing in the West: a pedometer-based walking programme in combination with a physical activity consultation with a 12-month follow-up

The "Walking for Wellbeing in the West" randomised controlled trial of a pedometer-based walking programme in combination with a physical activity consultation with a 12-month follow-up

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN88907382
Enrollment
79
Registered
2008-03-31
Start date
2007-07-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Promotion of physical activity in the general population Not Applicable Physical activity

Interventions

Participants were randomised into one of two groups: immediate intervention (Group 1) or waiting list control (Group 2). Participants randomised to Group 1 received a 30 minute physical activity con

Sponsors

University of Strathclyde (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Men and women, aged 18 - 65 years 2. Able to understand the rationale behind the trial 3. Able to walk independently for 5 - 10 minutes 4. Those who speak English 5. Those who are in the precontemplation, contemplation or preparation stages of the transtheoretical model of behaviour change (with respect to meeting the current physical activity recommendations) using an adapted stage of change algorithm

Exclusion criteria

Exclusion criteria: Involved in regular activity (i.e., not in stages 1 - 3 of the transtheoretical model of behavioural change).

Design outcomes

Primary

MeasureTime frame
Walking behaviour: pedometer step counts (Omron HJ-109E Step-O-Meter). Timepoints of measurement: Intervention group - at baseline, 3, 6 and 12 months Control group - at baseline, 3, 6, 9 and 15 months

Secondary

MeasureTime frame
1. Walking behaviour: seven-day recall of physical activity using the International Physical Activity Questionnaire (IPAQ) (long version, self-report). This will be assessed at baseline, 3 , 6 and 12 months (intervention) and at baseline, 3, 6, 9 and 15 months (control). 2. Psychological: the four constructs of the Transtheoretical Model (stages of change, processes of change, self efficacy, and decisional balance questionnaires), along with mood (Positive and Negative Affect Schedule [PANAS] questionnaires) and quality of life (European Quality of Life [EQ-5D] questionnaires). This will be assessed at baseline, 12, 24 and 48 weeks (intervention) and at baseline, 12, 24, 36 and 60 weeks (control). 3. Physiological: Body composition, blood pressure, heart rate, total cholesterol, high density lipoprotein (HDL) cholesterol, insulin and glucose, and circulating levels of inflammatory markers. For the intervention group, all physiological measures were taken at baseline and 12 weeks. At 24 weeks body mass, body mass index (BMI), waist-to-hip ratio, percentage body fat, blood pressure and heart rate were assessed. In the control group, all physiological measures were assessed at baseline, 12 week and 24 weeks. At 36 weeks body mass, BMI, waist-to-hip ratio, percentage body fat, blood pressure and heart rate were assessed. 4. Environmental: perceived (subjective) environmental barriers or facilitators to activity, and also any changes in physical activity levels and environmental perceptions over the course of the study using the Neighbourhood Quality of Life Study (1st Survey; NQLS). Questionnaires were completed at baseline, 12 weeks, 24 weeks and 48 weeks (interverntion) and at baseline, 12 weeks, 24 weeks, 36 weeks and 60 weeks (control). An environmental audit tool and geographic information system (GIS) data provides an objective assessment of the study area in relation to walking. 5. Qualitative: a qualitative evaluation is being undertaken alongside the main rand

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 5, 2026